A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signatures on their surface.
Duke University researchers fashioned the simple circuits from interacting strands of synthetic DNA that are tens of thousands of times finer than a human hair.
Unlike the circuits in a computer, these circuits work by attaching to the outside of a cell and analyzing it for proteins found in greater numbers on some cell types than others. If a circuit finds its targets, it labels the cell with a tiny light-up tag.
Because the devices distinguish cell types with higher specificity than previous methods, the researchers hope their work might improve diagnosis, and give cancer therapies better aim.
A team led by Duke computer scientist John Reif and his former Ph.D. student Tianqi Song described their approach in a recent issue of the Journal of the American Chemical Society.
Similar techniques have been used previously to detect cancer, but they’re more prone to false alarms — misidentifications that occur when mixtures of cells sport one or more of the proteins a DNA circuit is designed to screen for, but no single cell type has them all.
For every cancer cell that is correctly detected using current methods, some fraction of healthy cells also get mislabeled as possibly cancerous when they’re not.
Each type of cancer cell has a characteristic set of cell membrane proteins on its cell surface. To cut down on cases of mistaken identity, the Duke team designed a DNA circuit that must latch onto that specific combination of proteins on the same cell to work.
As a result they’re much less likely to flag the wrong cells, Reif said.
The technology could be used as a screening tool to help rule out cancer, which could mean fewer unnecessary follow-ups, or to develop more targeted cancer treatments with fewer side effects.
Each basic element of their DNA circuit consists of two DNA strands. The first DNA strand folds over and partially pairs up with itself to form a hairpin shape. One end of each hairpin is bound to a second strand of DNA that acts as a lock and tether, folding in such a way to fit a specific cell surface protein like a puzzle piece. Together these two strands act to verify that that particular protein is present on the cell surface.
To look for cancer, the circuit components are mixed with a person’s cells in the lab. If any cells are studded with the right combination of proteins, the complete circuit will attach. Adding a strand of “initiator” DNA then causes one of the hairpins to open, which in turn triggers another in a chain reaction until the last hairpin in the circuit is opened and the cell lights up.
Test runs of the device in test tubes in Reif’s lab showed it can be used to detect leukemia cells and to distinguish them from other types of cancer within a matter of hours, just by the strength of their glow.
The devices can be easily reconfigured to detect different cell surface proteins by replacing the tether strands, the researchers say. In the future, Reif plans to expand the device to release a small molecule that alerts the body’s immune system to attack the cancer cell.
The technology isn’t ready for prime time yet. The researchers say their DNA circuits require testing in more realistic conditions to make sure they still flag the right cells.
But it’s a promising step toward ensuring that cancer screens and therapies zero in on the right culprits.
Learn more: I.D. VERIFICATION, NOW FOR CANCER
The Latest Google Headlines on:
The Latest Bing News on:
- Plan proposed to make NHS owner of cancer blood test technologyon October 20, 2021 at 1:06 am
Plan proposed to make NHS owner of cancer blood test technology One of the UK’s leading authorities on human proteomics is seeking to establish a publicly owned foundation that will make the National ...
- DNA vaccines: ready for prime time?on October 20, 2021 at 1:03 am
Since the discovery, over a decade and a half ago, that genetically engineered DNA can be delivered in vaccine form and elicit an immune response, there has been much progress in understanding the ...
- Biotage acquires ATDBio and strengthens its position in DNA and RNA Oligonucleotide synthesis and purificationon October 19, 2021 at 11:39 pm
Biotage AB (publ) ("Biotage") has today entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited ("ATDBio") based in Oxford and Southampton, UK, for a ...
- Utah lab examining evidence from Atlanta Child Murder specializes in generating DNA from degraded sampleson October 19, 2021 at 9:53 pm
Sorenson Forensics in Salt Lake City is the DNA lab helping Atlanta Police confirm if Wayne Williams is the person who killed more than two dozen children.
- Case Western Reserve technology helps launch New York company's IPOon October 19, 2021 at 9:49 pm
Lucid Diagnostics Inc., a subsidiary of New York-based PAVmed Inc., licensed its EsoCheck and EsoGuard technology through Case Western Reserve's Technology Transfer Office in 2018, the university said ...
- Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chainon October 19, 2021 at 9:01 pm
With Applied DNA and CertainT, our customers can now trust in the original ... anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and ...
- So-Called Junk DNA – Genetic “Dark Matter” – Is Actually Critical to Survival in Mammalson October 19, 2021 at 6:21 pm
Knocking out transposon promoter leads to pup death in mice; similar promoters found in many mammals. Nearly half of our DNA has been written off as junk, the discards of evolution: sidelined or ...
- Utah lab to examine DNA evidence from Atlanta child murderson October 19, 2021 at 4:40 pm
DNA evidence linked to the Atlanta child murders will be tested by a private lab in Utah with the hope The post Utah lab to examine DNA evidence from Atlanta child murders appeared first on ...
- Utah lab to analyze DNA evidence from Atlanta child murderson October 19, 2021 at 12:55 pm
Atlanta Mayor Keisha Lance Bottoms says a Utah laboratory will examine DNA evidence from a string of killings committed during the 1970s and 1980s.
- Purigen Biosystems Enables Scientists to Extract and Purify Higher Yields of DNA from Fresh Frozen Tissue Sampleson October 19, 2021 at 5:03 am
New automated Ionic® Tissue to Pure DNA Kit recovers more than three times the amount of high-quality nucleic acid from limited samples compared to leading column-based products PLEASANTON, ...
The Latest Google Headlines on:
Targeted cancer treatments
The Latest Bing News on:
Targeted cancer treatments
- Targeted prostate cancer screening could benefit men with inherited cancer syndromeon October 20, 2021 at 12:42 am
Targeted prostate cancer screening could benefit men with inherited cancer syndromeAnnual PSA tests eight times more likely to spot cancer in men with genetic hallmarks of Lynch syndrome than those ...
- Crescendo Biologics Announces Prestigious New Collaboration With the Institute of Cancer Research, Londonon October 20, 2021 at 12:00 am
Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, today announces a new translational science collaboration with ...
- Deep learning algorithm can accurately detect molecular pathways, key mutations in colorectal canceron October 19, 2021 at 9:43 pm
A new deep learning algorithm created by researchers from the University of Warwick can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than ...
- Targeting cancer at the nanoscaleon October 19, 2021 at 9:10 am
Osaka University researchers fabricate gold nanoparticles with a rapidly decaying radioisotope that can be internalized by cancer cells. Because the radiation remains strongly localized, high doses ...
- With targeted treatments, cancer is no longer a death sentenceon October 19, 2021 at 8:02 am
BECAUSE OF advances in cancer therapy and prevention efforts, patients have a higher chance of surviving cancer and living a full life as a cancer survivor.
- Targeted prostate cancer screening ‘could benefit men with inherited syndrome’on October 19, 2021 at 5:00 am
Researchers believe targeted annual screening from the age of 40 could lead to earlier diagnosis and treatment of prostate cancer.
- BRCA2 gene investigation may help to design targeted cancer treatmenton October 18, 2021 at 6:05 am
Researchers make advancement in targeted therapy for cancer, identifying the pivotal role that the BRCA2 gene plays in the deadly disease.
- New Discovery Paves the Way for More Targeted Cancer Treatmenton October 17, 2021 at 9:00 am
B56, to be able to repair DNA damage. The researchers hope the study may provide important information about potential breast cancer risk.
- New discovery may pave the way for more targeted treatment of cancer patientson October 15, 2021 at 8:41 am
Women with certain mutations in BRCA2 have an increased risk of breast and ovarian cancer. In a new study, researchers from the University of Copenhagen show that BRCA2 requires a specific enzyme in ...
- AR-targeted therapies for advanced prostate canceron October 14, 2021 at 6:58 am
Julie N. Graff, MD, of OHSU Knight Cancer Institute, comments on the impact of the availability of newer-generation androgen receptor inhibitors on treatment outcomes for patients with advanced ...